| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Innoveren Scientific, Inc. | 10%+ Owner | COMMON STOCK | 344,716 | $582,524 | $0.0140 | 16 Jan 2024 | Indirect |
| Innoveren Scientific, Inc. | 10%+ Owner | SERIES A PREFERRED STOCK | 33,682,000 | 16 Jan 2024 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000106615224000001-wagner-todd-r-2024-01-16 | Innoveren Scientific, Inc. | 16 Jan 2024 | 2 | $0 | 4 | 10%+ Owner | 18 Jan 2024, 16:26 |
| /report/000106615222000001-wagner-todd-r-2022-02-23 | H-CYTE, INC. | 23 Feb 2022 | 3 | +$1,165,049 | 4 | 10%+ Owner | 25 Feb 2022, 15:11 |